- Capital Cube•27 days ago
IDT Australia Ltd. :IDT-AU: Earnings Analysis: For the six months ended December 31, 2016 : February 24, 2017
Categories: Yahoo Finance Get free summary analysis IDT Australia Ltd. reports financial results for the half-year ended December 31, 2016. We analyze the earnings along side the following peers of IDT Australia Ltd. – Medical Developments International Limited (MVP-AU) that have also reported for this period. Highlights Summary numbers: Revenues of AUD 4.89 million, Net Earnings of AUD ... Read more (Read more...)
- PR Newswire•4 months ago
MELBOURNE, Australia, Nov. 22, 2016 /PRNewswire/ -- Mayne Pharma Group Limited (Mayne Pharma, ASX:MYX) has today announced the U.S. launch of IDT's generic temozolomide 5mg, 20mg, 100mg, 140mg, 180mg and ...
- PR Newswire•5 months ago
PharmaVentures Advises IDT Australia on the Divestment of CMAX Clinical Trial Business to the Japanese Company I'rom Group Co. Ltd.
The acquisition is subject to the satisfaction of certain conditions precedent, and as part of the agreed upon structure of the deal, IDT will establish and integrate the CMAX business within a new company (henceforth referred to as NewCo). This will allow I'rom Group to integrate the CMAX business and to learn from IDT's experience in managing CMAX, paving the way for I'rom Group to acquire the remaining shares of NewCo over the next twelve months.
IDT.AX : Summary for IDT AUST FPO - Yahoo Finance
IDT Australia Limited (IDT.AX)
ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
|Day's Range||0.13 - 0.13|
|52 Week Range||0.12 - 0.41|
|PE Ratio (TTM)||2.71|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|